The cell-intrinsic effect of CTLA-4 blockade on effector T cells has been shown in mice and humans to be the primary mechanism for the anti-tumor effect, rather than its effect on Treg cells (37, 38). The gene discussed is CTLA4; the disease is neoplasm.